BIENAIME JEAN JACQUES 4

What Happened
Jean Jacques Bienaime, a director of Incyte Corporation (INCY), received equity awards reported on Form 4 dated 2026-06-08. The filing shows (1) 1,642 shares acquired at $0.00 and (2) 6,111 derivative shares (RSUs) acquired at $0.00. The reported grants are awards of restricted stock units (RSUs) that do not reflect a cash purchase or sale.

Key Details

• Transaction date: 2026-06-08; filing date (Form 4): 2026-06-10 — appears timely.
• Reported items: 1,642 shares @ $0.00 (acquired) and 6,111 shares @ $0.00 (derivative/RSU). Total reported units: 7,753.
• Vesting and settlement: Footnote F1 — RSUs vest in full on the first anniversary of the grant (or earlier at the next annual meeting or on a change of control) and settle one-for-one into common shares.
• Footnote F2 notes the 1,642 shares are part of an aggregate of previously reported unvested RSUs.
• Footnote F3 describes a standard one-year vesting for an option (if applicable to other awards disclosed).
• Shares owned after the transaction are not specified in the excerpt provided.

Context
This was an equity award (grant of RSUs), not an open-market buy or sale. RSU grants are common compensation for directors and reflect future claims to stock that vest per the schedule above; they do not indicate an immediate cash outlay or sale. For retail investors, awards are informative about compensation and potential future share issuance but are not the same signal as a director purchasing shares on the open market.